Robert Rissman’s science research focuses on novel biomarker discovery and experimental neuropathology in Alzheimer’s disease (AD), Parkinson’s disease (PD), and preclinical animal models. In addition to his basic science research program, he also serves as the Director for several cores at UCSD and neighboring USC campus. He is the Founding Director of UCSD’s Alzheimer’s Disease Cooperative Study (ADCS) Biomarker Core and USC’s Alzheimer’s Therapeutic Research Institute (ATRI) in San Diego, and Alzheimer’s Clinical Trials Consortium (ACTC) which serve AD clinical trials. He is also the Director of UCSD’s Alzheimer’s Disease Research Center (ADRC) Neuropathology and Biomarker Cores and the UCSD ADRC Brain Bank. He serves as PI at the VA San Diego where his lab is focused on understanding how central corticotropin-releasing factor (CRF) neuromodulatory pathways interplay with peripheral stress signaling and contributes to neuronal vulnerability and AD neuropathology using in vivo pharmacology in transgenic animal models and human biospecimens.
09/08 – present
Associate Professor of Neurosciences, UCSD
04/16 – present
Principal Investigator/Research Biologist, VA San Diego Healthcare System